Measuring the burden of opioid-related mortality in Ontario, Canada
Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. J Addict Med. 2018; 12(5):418-9. Epub 2018 Apr 25.
Publications
Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada
Minhas R, Tadrous M, Elterman D, Gomes T. Neurourol Urodyn. 2018; 37(5):1693-700. Epub 2018 Apr 23.
Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program
Tadrous M, Greaves S, Martins D, Mamdani MM, Juurlink DN, Gomes T. CMAJ Open. 2018; 6(1):E132-8. Epub 2018 Mar 26.
Opioid prescribing and adverse events in opioid-naive patients treated by emergency physicians versus family physicians: a population-based cohort study
Borgundvaag B, McLeod S, Khuu W, Varner C, Tadrous M, Gomes T. CMAJ Open. 2018; 6(1):E110-7. Epub 2018 Mar 5.
Publicly funded overactive bladder drug treatment patterns in Ontario over 15 years: an ecologic study
Tadrous M, Elterman D, Khuu W, Mamdani MM, Juurlink DN, Gomes T. Can Urol Assoc J. 2018; 12(3):E142-5. Epub 2017 Dec 22.
Prior authorization and Canadian public utilization of direct-acting oral anticoagulants
Gao L, Tadrous M, Knowles S, Mamdani M, Paterson JM, Juurlink D, Gomes T. Healthc Policy. 2017; 13(2):68-78.
Real-world healthcare utilization and effectiveness of omalizumab for the treatment of severe asthma
Tadrous M, Khuu W, Lebovic G, Stanbrook MB, Martins D, Paterson JM, Mamdani MM, Juurlink DN, Gomes T. Ann Allergy Asthma Immunol. 2018; 120(1):59-65.e2. Epub 2017 Oct 3.
Antipsychotic use with and without comorbid psychiatric diagnosis among adults with intellectual and developmental disabilities
Lunsky Y, Khuu W, Tadrous M, Vigod S, Cobigo V, Gomes T. Can J Psychiatry. 2018; 63(6):361-9. Epub 2017 Aug 23.
Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014
Guan Q, Khuu W, Spithoff S, Kiran T, Kahan M, Tadrous M, Martins D, Leece P, Gomes T. Drug Alcohol Depend. 2017; 177:315-21. Epub 2017 Jul 19.
Impact of unrestricted access to pregabalin on the use of opioids and other CNS-active medications: a cross-sectional time series analysis
Kwok H, Khuu W, Fernandes K, Martins D, Tadrous M, Singh S, Juurlink DN, Gomes T. Pain Med. 2017; 18(6):1019-26. Epub 2017 Mar 6.